Literature DB >> 4957609

Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.

A S Youmans, G P Youmans.   

Abstract

Youmans, Anne S. (Northwestern University Medical School, Chicago, Ill.), and Guy P. Youmans. Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. J. Bacteriol. 91:2139-2145. 1966.-Ribosomal fractions of Mycobacterium tuberculosis, strain H37Ra, were prepared by treatment of the intracellular particulate fraction with 0.25 or 0.5% sodium dodecylsulfate (SDS) followed by centrifugation at 144,700 x g for 3 hr. This procedure has greatly simplified the preparation of ribosomal fractions and has given fractions composed of approximately 50% ribonucleic acid (RNA) and 15 to 20% protein. When incorporated into Freund's incomplete adjuvant and injected intraperitoneally into CF-1 mice, the SDS ribosomal fractions were more immunogenic than the particulate fractions from which they were prepared. They were as much as 100 times more immunogenic than ribosomal fractions prepared by differential centrifugation, 1 mug (dry weight) per mouse being sufficient for the induction of some immunity. However, none of these ribosomal preparations, in comparable doses, was as immunogenic as the living cells from which they were prepared. It was also shown that the addition of 10(-4)m MgCl(2) to the final diluent increased immunogenic activity, whereas larger concentrations (10(-3)m) reduced immunogenic activity. Preparation of the ribosomal fraction from ruptured cells in one continuous process during the course of 1 day increased the activity. Two-week-old H37Ra cells contained more RNA and were more immunogenic than the older cultures which have been used in the past.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4957609      PMCID: PMC316185          DOI: 10.1128/jb.91.6.2139-2145.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

1.  The nature of the fluctuating ribonucleic acid in Escherichia coli.

Authors:  H E WADE; D M MORGAN
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

2.  The preparation and characterization of ribonucleic acids from yeast.

Authors:  A M CRESTFIELD; K C SMITH; F W ALLEN
Journal:  J Biol Chem       Date:  1955-09       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  The enumeration of viable tubercle bacilli by surface plate counts.

Authors:  F FENNER
Journal:  Am Rev Tuberc       Date:  1951-10

5.  The metabolism of exogenous ribonucleic acids injected into mice.

Authors:  S Sved
Journal:  Can J Biochem       Date:  1965-07

6.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

7.  Nonspecific factors in resistance of mice to experimental tuberculosis.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1965-12       Impact factor: 3.490

8.  The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis.

Authors:  G P YOUMANS; A S YOUMANS
Journal:  J Immunol       Date:  1957-05       Impact factor: 5.422

9.  IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

10.  Liver microsomes; an integrated morphological and biochemical study.

Authors:  G E PALADE; P SIEKEVITZ
Journal:  J Biophys Biochem Cytol       Date:  1956-03-25
View more
  37 in total

1.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

2.  Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.

Authors:  F B Michel; L Dussourd D'Hinterland; J Bousquet; A M Pinel; G Normier
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

3.  Lysed BCG vaccines. 1. Observations on optimal conditions for BCG growth and lysis.

Authors:  H Sato; B B Diena; L Greenberg
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

4.  Resolution and identification of ribosomes from mycobacteria.

Authors:  L Trnka; E Wiegeshaus; D W Smith
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

5.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

6.  Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.

Authors:  R G Neiburger; G P Youmans; A S Youmans
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

7.  The immunogenic activity of ribosomal fractions derived from Brucella abortus.

Authors:  M J Corbel
Journal:  J Hyg (Lond)       Date:  1976-02

8.  Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

Authors:  A S Youmans; G P Youmans; D Cahall
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

9.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

10.  Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.

Authors:  T Baba
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.